what influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?
Published 8 years ago • 119 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
2:00
the potential of studying circulating plasma cells in multiple myeloma
-
2:28
b-cells and pre-plasma cells are important reservoirs responsible for relapse in multiple myeloma
-
0:59
defining the origins of multiple myeloma
-
3:05
identifying new therapeutic targets on the surfaceome of myeloma plasma cells with proteomics
-
1:33
circulating tumor cells in multiple myeloma
-
50:47
monitoring circulating plasma cells in routine diagnostics in multiple myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
3:03
what is plasma cell percentage and why is it measured in the bone marrow?
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:49
circulating tumor cell burden as a component of staging in multiple myeloma
-
4:22
prognostic value of mrd and circulating plasma cells in myeloma
-
2:24
the importance of molecular testing in multiple myeloma and how this may impact future treatment
-
1:47
the role of precursor conditions in myeloma
-
2:42
the value of circulating tumor cells for the staging of patients with ndmm
-
3:00
current & emerging biomarkers in multiple myeloma
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
1:11
defining precursor states in multiple myeloma
-
2:23
multiple myeloma: extramedullary disease
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:18
unmet needs for extramedullary disease in multiple myeloma
-
3:05
recent advances in newly diagnosed multiple myeloma and the importance of patient perspectives